Atossa Therapeutics
ATOS
#9542
Rank
A$0.10 B
Marketcap
A$0.81
Share price
-5.83%
Change (1 day)
-40.65%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): A-$0.38

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.36. In 2024 the company made an earnings per share (EPS) of A-$0.29 an increase over its 2023 EPS that were of A-$0.34.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.3832.02%
2024A-$0.29-16.67%
2023A-$0.3414.29%
2022A-$0.3016.67%
2021A-$0.26-90.86%
2020A-$2.83-2.96%
2019A-$2.92-63.09%
2018A-$7.90-49.63%
2017A-$15.68-57.87%
2016A-$37.22-74.01%
2015A-$143.20-9.18%
2014A-$157.67-12.86%
2013A-$180.9470.73%
2012A-$105.9834.08%
2011A-$79.04263.47%
2010A-$21.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$14.99-4,275.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$12.41-3,556.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$14.72-4,200.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A-$1.26 252.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A-$0.30-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA